Utility of rat liver s9 fractions to study skin-sensitizing prohaptens in a modified keratinosens assay

Toxicological Sciences

Volumn 135, Issue 2, 2013, Pages 356-368

  Natsch, Andreas ^a   Haupt, Tina ^a  

^a GIVAUDAN SCHWEIZ AG   (Switzerland)

Author keywords

In vitro testing; Nuclear factor erythroid 2 related factor 2; Prohaptens; Reporter gene; S9 fractions; Skin sensitization

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 1 NAPHTHOL; 2 ETHOXY METHYL PHENOL; 2 PROPANOL; 3 AMINOPHENOL; 4 HYDROXYBENZOIC ACID; ALKADIENE; ANETHOLE; AROCLOR; BENZOIC ACID; BUTANOL; CARVONE OXIME; CINNAMALDEHYDE; DIHYDROEUGENOL; DODECYL SULFATE SODIUM; ESTRAGOLE; EUGENOL; GLYCEROL; HAPTEN; LUCIFERASE; METHYLISOEUGENOL; PARACETAMOL; PHTHALIC ACID DIETHYL ESTER; PROPYLENE GLYCOL; RESORCINOL; SALICYLIC ACID; SALICYLIC ACID METHYL ESTER; SULFANILAMIDE; SULFANILIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GENE INDUCTION; IN VITRO STUDY; METABOLIC ACTIVATION; NONHUMAN; RAT; SCREENING; SKIN SENSITIZATION;

IN VITRO TESTING; NUCLEAR FACTOR-ERYTHROID 2-RELATED FACTOR 2.; PROHAPTENS; REPORTER GENE; S9 FRACTIONS; SKIN SENSITIZATION;

ANIMALS; BIOTRANSFORMATION; CELL LINE; CYTOCHROME P-450 ENZYME SYSTEM; HAPTENS; LIVER; RATS;

EID: 84886471931     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft160     Document Type: Article

References (43)

1. Ashby, J., Basketter, D. A., Paton, D., and Kimber, I. (1995). Structure activity relationships in skin sensitization using the murine local lymph node assay. Toxicology 103, 177-194.
2. Ball, N., Cagen, S., Carrillo, J. C., Certa, H., Eigler, D., Emter, R., Faulhammer, F., Garcia, C., Graham, C., Haux, C., et al. (2011). Evaluating the sensitization potential of surfactants: Integrating data from the local lymph node assay, guinea pig maximization test, and in vitro methods in a weight-ofevidence approach. Regul. Toxicol. Pharmacol. 60, 389-400.
3. Baron, J. M., Holler, D., Schiffer, R., Frankenberg, S., Neis, M., Merk, H. F., and Jugert, F. K. (2001). Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J. Invest. Dermatol. 116, 541-548.
4. Baron, J. M., Zwadlo-Klarwasser, G., Jugert, F., Hamann, W., Rubben, A., Mukhtar, H., and Merk, H. F. (1998). Cytochrome P450 1B1: A major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem. Pharmacol. 56, 1105-1110.
5. Barratt, M. D., and Basketter, D. A. (1992). Possible origin of the skin sensitization potential of isoeugenol and related compounds. (I). Preliminary studies of potential reaction mechanisms. Contact Dermatitis 27, 98-104.
6. Bergstrom, M. A., Luthman, K., and Karlberg, A. T. (2007). Metabolic epoxidation of an alpha,beta-unsaturated oxime generates sensitizers of extreme potency. Are nitroso intermediates responsible? Chem. Res. Toxicol. 20, 927-936.
7. Bergstrom, M. A., Ott, H., Carlsson, A., Neis, M., Zwadlo-Klarwasser, G., Jonsson, C. A., Merk, H. F., Karlberg, A. T., and Baron, J. M. (2007). A skinlike cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J. Invest. Dermatol. 127, 1145-1153.
8. Bickers, D. R., Dutta-Choudhury, T., and Mukhtar, H. (1982). Epidermis: A site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity. Mol. Pharmacol. 21, 239-247.
9. Billinton, N., Bruce, S., Hansen, J. R., Hastwell, P. W., Jagger, C., McComb, C., Klug, M. L., Pant, K., Rabinowitz, A., Rees, R., et al. (2010). A pre-validation transferability study of the GreenScreen HC GADD45a-GFP assay with a metabolic activation system (S9). Mutat. Res. 700, 44-50.
10. Bonifas, J., Hennen, J., Dierolf, D., Kalmes, M., and Blomeke, B. (2010). Evaluation of cytochrome P450 1 (CYP1) and N-acetyltransferase 1 (NAT1) activities in HaCaT cells: Implications for the development of in vitro techniques for predictive testing of contact sensitizers. Toxicol. In Vitro 24, 973-980.
11. Cheung, C., Hotchkiss, S. A., and Pease, C. K. (2003). Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency. J. Dermatol. Sci. 31, 9-19.
12. Chipinda, I., Blachere, F. M., Anderson, S. E., and Siegel, P. D. (2011a). Discrimination of haptens from prohaptens using the metabolically deficient Cpr(low/low) mouse. Toxicol. Appl. Pharmacol. 252, 268-272.
13. Chipinda, I., Ruwona, T. B., Templeton, S. P., and Siegel, P. D. (2011b). Use of the human monocytic leukemia THP-1 cell line and co-incubation with microsomes to identify and differentiate hapten and prohapten sensitizers. Toxicology 280, 135-143.
14. Emter, R., Ellis, G., and Natsch, A. (2010). Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol. Appl. Pharmacol. 245, 281-290.
15. Gerberick, G. F., Troutman, J. A., Foertsch, L. M., Vassallo, J. D., Quijano, M., Dobson, R. L., Goebel, C., and Lepoittevin, J. P. (2009). Investigation ofpeptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol. Sci. 112, 164-174.
16. Hagvall, L., Baron, J. M., Borje, A., Weidolf, L., Merk, H., and Karlberg, A. T. (2008). Cytochrome P450-mediated activation of the fragrance compound geraniol forms potent contact allergens. Toxicol. Appl. Pharmacol. 233, 308-313.
17. Hennen, J., Aeby, P., Goebel, C., Schettgen, T., Oberli, A., Kalmes, M., and Blomeke, B. (2011). Cross talk between keratinocytes and dendritic cells: Impact on the prediction of sensitization. Toxicol. Sci. 123, 501-510.
18. Hilton, I., Dearman, R. J., Fielding, I., Basketter, D. A., and Kimber, I. (1996). Evaluation of the sensitizing potential of eugenol and isoeugenol in mice and guinea pigs. J. Appl. Toxicol. 16, 459-464.
19. Itoh, M. (1982). Sensitization potency of some phenolic compounds-with special emphasis on the relationship between chemical structure and allergenicity. J. Dermatol. 9, 223-233.
20. Jackh, C., Blatz, V., Fabian, E., Guth, K., van Ravenzwaay, B., Reisinger, K., and Landsiedel, R. (2011). Characterization of enzyme activities of Cytochrome P450 enzymes, Flavin-dependent monooxygenases, N-acetyltransferases and UDP-glucuronyltransferases in human reconstructed epidermis and fullthickness skin models. Toxicol. In Vitro 25, 1209-1214.
21. Jagger, C., Tate, M., Cahill, P. A., Hughes, C., Knight, A. W., Billinton, N., and Walmsley, R. M. (2009). Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay. Mutagenesis 24, 35-50.
22. Karlberg, A. T., Bergstrom, M. A., Borje, A., Luthman, K., and Nilsson, J. L. (2008). Allergic contact dermatitis-formation, structural requirements, and reactivity of skin sensitizers. Chem. Res. Toxicol. 21, 53-69.
23. Kern, P. S., Gerberick, G. F., Ryan, C. A., Kimber, I., Aptula, A., and Basketter, D. A. (2010). Local lymph node data for the evaluation of skin sensitization alternatives: A second compilation. Dermatitis 21, 8-32.
24. Lalko, J. F., Kimber, I., Gerberick, G. F., Foertsch, L. M., Api, A. M., and Dearman, R. J. (2012). The direct peptide reactivity assay: Selectivity of chemical respiratory allergens. Toxicol. Sci. 129, 421-431.
25. Lou, H., Du, S., Ji, Q., and Stolz, A. (2006). Induction of AKR1C2 by phase II inducers: Identification of a distal consensus antioxidant response element regulated by NRF2. Mol. Pharmacol. 69, 1662-1672.
26. Luu-The, V., Duche, D., Ferraris, C., Meunier, J. R., Leclaire, J., and Labrie, F. (2009). Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin and full thickness model from Episkin. J. Steroid Biochem. Mol. Biol. 116, 178-186.
27. Marzulli, F. N., and Maibach, H. I. (1980). Contact allergy: Predictive testing of fragrance ingredients in humans by Draize and Maximization methods. J. Environ. Pathol. Toxicol. 3, 235-245.
28. McNeilly, A. D., Woods, J. A., Ibbotson, S. H., Wolf, C. R., and Smith, G. (2012). Characterization of a human keratinocyte HaCaT cell line model to study the regulation of CYP2S1. Drug Metab. Dispos. 40, 283-289.
29. Modi, B. G., Neustadter, J., Binda, E., Lewis, J., Filler, R. B., Roberts, S. J., Kwong, B. Y., Reddy, S., Overton, J. D., Galan, A., et al. (2012). Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science 335, 104-108.
30. Natsch, A. (2010). The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers-functional relevance and a hypothesis on innate reactions to skin sensitizers. Toxicol. Sci. 113, 284-292.
31. Natsch, A., Bauch, C., Foertsch, L., Gerberick, F., Normann, K., Hilberer, A., Inglis, H., Landsiedel, R., Onken, S., Reuter, H., et al. (2011). The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: Results of a ring-study in five laboratories. Toxicol. In Vitro 25, 733-744.
32. Natsch, A., and Gfeller, H. (2008). LC-MS-based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential. Toxicol. Sci. 106, 464-478.
33. Natsch, A., Ryan, C. A., Foertsch, L., Emter, R., Jaworska, J., Gerberick, G. F., and Kern, P. (2013). A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation. J. Appl. Toxicol. published online, 9 April 2013, doi:10.1002/jat.2868.
34. Nilsson, A. M., Bergstrom, M. A., Luthman, K., Nilsson, J. L., and Karlberg, A. T. (2005a). An alpha,beta-unsaturated oxime identified as a strong contact allergen. Indications of antigen formation via several pathways. Food Chem. Toxicol. 43, 1627-1636.
35. Nilsson, A. M., Bergstrom, M. A., Luthman, K., Nilsson, J. L., and Karlberg, A. T. (2005b). A conjugated diene identified as a prohapten: Contact allergenic activity and chemical reactivity of proposed epoxide metabolites. Chem. Res. Toxicol. 18, 308-316.
36. Ott, H., Bergstrom, M. A., Heise, R., Skazik, C., Zwadlo-Klarwasser, G., Merk, H. F., Baron, J. M., and Karlberg, A. T. (2009). Cutaneous metabolic activation of carvoxime, a self-activating, skin-sensitizing prohapten. Chem. Res. Toxicol. 22, 399-405.
37. Patten, C. J., Thomas, P. E., Guy, R. L., Lee, M., Gonzalez, F. J., Guengerich, F. P., and Yang, C. S. (1993). Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. 6, 511-518.
38. Scholes, E. W., Pendlington, R. U., Sharma, R. K., and Basketter, D. A. (1994). Skin metabolism of contact allergens. Toxicol. In Vitro 8, 551-553.
39. Shvedova, A. A., Osipov, A. N., Jeffries, B. A., Kommineni, C., Vallyathan, V., and Castranova, V. (1999). Peroxidase/H2O2 enhances hypersensitivity responses induced by eugenol: Inhibitory effect of an antioxidant, lipoic acid. Environ. Nutr. Interact. 3, 15-31.
40. Thompson, D., Constantin-Teodosiu, D., Egestad, B., Mickos, H., and Moldeus, P. (1990). Formation of glutathione conjugates during oxidation of eugenol by microsomal fractions of rat liver and lung. Biochem. Pharmacol. 39, 1587-1595.
41. Troutman, J. A., Foertsch, L. M., Kern, P. S., Dai, H. J., Quijano, M., Dobson, R. L., Lalko, J. F., Lepoittevin, J. P., and Gerberick, G. F. (2011). The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments. Toxicol. Sci. 122, 422-436.
42. Uter, W., Geier, J., Frosch, P., and Schnuch, A. (2010). Contact allergy to fragrances: Current patch test results (2005-2008) from the Information Network of Departments of Dermatology. Contact Dermatitis 63, 254-261.
43. van Eijl, S., Zhu, Z., Cupitt, J., Gierula, M., Gotz, C., Fritsche, E., and Edwards, R. J. (2012). Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling. PLoS One 7, e41721